By Nathaniel Crouch
Tree of Knowledge International Corp (TOKI), a Canadian-based healthcare company which specializes in medical cannabis research, product development and education, announced a research project partnership with Ryerson. The project involves the development of nano-machines used to deliver CBD oil as an effective method in treating cancerous tumours and pain.
Science Daily, a science news publication based in Rockville, United States, defines nanotechnology as “A field of applied science and technology whose unifying theme is the control of matter on the molecular level in scales smaller than 1 micrometre, normally 1 to 100 nanometres, and the fabrication of devices within that size range.”
In easier terms for us Joes, it’s any technology where its size is measured in nanometers—a unit of measurement so small you can’t see it unless you used a microscope.
For reference, the average nickel is 21 millimetres and one million nanometres is equal to one millimetre. George Shrinks, eat your heart.
The team leading the project is at work to create a delivery system, called a nanocarrier, which is coated in Hemp CBD oil and guided via ultrasound to cancerous tumours or sources of pain in a patient’s body.
The goal of the project is to create targeted treatments for different medical conditions.
The ultrasound precision can target a variety of cancerous tumours.
TOKI’s sponsorship of the project is to support a team of five Ryerson researchers. The team is comprised of co-principal investigators Professor Jahan Tavakkoli and Professor Michael Kolios, and they are joined by a newly-hired full-time researcher, plus two Masters students. They’ll be leveraging the clinical application know-how of TOKI’s Medical advisor, Dr. Kevin Rod.
The research project is titled, “Development of ultrasound-mediated targeted delivery methods and treatments using medical Cannabis and/or Hemp CBD oil with applications in pain.”
It’s a mouthful, but the long title explains that the technology works in unison with TOKI’s ultrasound technology to apply medical cannabis directly to a tumour.
“Kicking off this research project at Ryerson today catalyzes innovative work we are proud of contributing to,” said Dr. Rod, in a press release. “Cancer is among the leading causes of death worldwide, and our team is well suited to fight it through this new technology.”